Parenteral Drugs India Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 25.965 million compared to INR 87.875 million a year ago. Net loss was INR 248.454 million compared to INR 319.346 million a year ago. Basic loss per share was INR 8.33 compared to INR 10.71 a year ago. For the full year, total revenue was INR 122.313 million compared to INR 321.266 million a year ago. Net loss was INR 1,217.129 million compared to INR 1,140.726 million a year ago. Basic loss per share was INR 40.82 compared to INR 38.36 a year ago.